Akèy › Nefwòz lipoyid › North Carolina
Etid klinik pou Nefwòz lipoyid nan North Carolina
4 etid pou Nefwòz lipoyid ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Ap rekrite
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.